1.
Ramsay S, Naud √Člizabeth, Simonyan D, Moore K, Bolduc S. A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study. CUAJ [Internet]. 2020 Jan. 20 [cited 2021 Oct. 17];14(6):192-8. Available from: https://cuaj.ca/index.php/journal/article/view/6247